We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

19 hedge funds and large institutions have $3.71M invested in TriSalus Life Sciences Warrant in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more capital invested

Capital invested by funds: $3.33M → $3.71M (+$376K)

1.76% less ownership

Funds ownership: 9.84% → 8.07% (-1.8%)

10% less funds holding

Funds holding: 21 → 19 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
5
Closed
4
Calls
$384K
Puts
–
Net Calls
+$384K
Net Calls Change
-$721K

Top Buyers

1
BCM
Bluefin Capital Management
New York
+$157K
2
CCC
Cable Car Capital
California
+$103K
3
FVWA
Foster Victor Wealth Advisors
South Carolina
+$251

Top Sellers

1
MF
Magnetar Financial
Illinois
-$170K
2
EAM
Exos Asset Management
New York
-$168K
3
WAM
Wolverine Asset Management
Illinois
-$117K
4
KL
KIM LLC
Kansas
-$81.4K
5
AC
Aristeia Capital
Connecticut
-$58.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
MF
1
Magnetar Financial
Illinois
$1.17M -$170K -125,000 -16%
DM
2
Deerfield Management
New York
$543K – – –
PAMP
3
Polar Asset Management Partners
Ontario, Canada
$430K -$36.1K -26,602 -9%
VI
4
Vestcor Inc
New Brunswick, Canada
$242K – – –
MP
5
MSD Partners
New York
$217K – – –
BCM
6
Bluefin Capital Management
New York
$211K +$157K +115,989 New
BCL
7
Bracebridge Capital LLC
Massachusetts
$151K – – –
Walleye Capital
8
Walleye Capital
New York
$147K – – –
CCC
9
Cable Car Capital
California
$124K +$103K +76,287 New
SFA
10
Sequoia Financial Advisors
Ohio
$103K – – –
CM
11
CastleKnight Management
New York
$84.4K – – –
Walleye Trading
12
Walleye Trading
New York
$82.8K – – –
HF
13
HRT Financial
New York
$54K -$34 -25 -0.1%
KL
14
KIM LLC
Kansas
$34.6K -$81.4K -60,000 -76%
ACM
15
Alpha Capital Management
Texas
$33.3K – – –
CAC
16
Cowen and Company
New York
$33.2K -$40.8K -30,055 -60%
FVWA
17
Foster Victor Wealth Advisors
South Carolina
$27.1K +$251 +185 +0.9%
Nomura Holdings
18
Nomura Holdings
Japan
$19.7K – – –
TRCT
19
Tower Research Capital (TRC)
New York
$70 – – –
EAM
20
Exos Asset Management
New York
– -$168K -167,610 Closed
WAM
21
Wolverine Asset Management
Illinois
– -$117K -117,290 Closed
AC
22
Aristeia Capital
Connecticut
– -$58.9K -53,561 Closed
CS
23
Clear Street
New York
– -$41.2K -41,169 Closed

TLSIW Hedge Fund Activity: Q2 2024 in Review

19 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q2 2024, worth a combined $3.71M — up 11% from $3.33M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of TLSIW and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 1 added.

The largest buyer was Bluefin Capital Management, opening a new position worth an estimated $157K. The largest seller was Magnetar Financial, cutting an estimated $170K.

  • 19 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q2 2024, down from 21 in Q1 2024.
  • Funds reported $3.71M of TriSalus Life Sciences Warrant stock for Q2 2024, up 11% quarter-over-quarter.
  • 2 funds opened new TriSalus Life Sciences Warrant positions in Q2 2024 and 4 closed out, a net change of -2 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q2 2024 was Bluefin Capital Management, an estimated $157K added.
  • The largest TriSalus Life Sciences Warrant seller in Q2 2024 was Magnetar Financial, an estimated $170K sold.

Based on aggregated 13F filings for Q2 2024.